INTRODUCTION
West Nile virus (WNV) is a member of the Flaviviridae family and it was first isolated in 1937 in the West Nile district of Uganda [1] . WNV is transmitted to animals including humans, through mosquito bites. Since 1999, when the virus was identified in the United States, the virus has spread rapidly and infected in the order of 15,000 people and caused more than 600 deaths.
There is currently no effective vaccine or antiviral drug to protect against WNV infection [2] .
WNV has a single strand, positive polarity, RNA genome. The 11 kilobase RNA genome codes for a single polyprotein precursor. The precursor is comprised of three structural proteins Anthrax 83 kDa protective antigen precursor (PA83) and the mature, trypsin-nicked 63 kDa protective antigen were purchased from List Labs (Campbell, CA). Furin was purified as described previously [23] .
MATERIALS AND METHODS

Reagents
Plasmid construction and cloning
The cDNA fragment of the pathogenic New York strain of WNV was used as a template to generate the NS2B-NS3 construct. We thank Dr. Richard Kinney, Centers for Disease Control and Prevention (Fort Collins, CO) for providing the WNV cDNA encoding NS2B and NS3. NS3 was generated by a PCR reaction using 5'-GGCGGGGGAGGTAGTGGTGGAGGCGGGGGAGGCGTGTTGTGGGACACTCCC-3' and 5'-CAGCATCTCAGGTTCGAATCCGGC-3' as direct and reverse primers, respectively. The 
Enzyme expression and purification
For protein purification, cells were resuspended in 20 ml lysis buffer (PBS, containing 1 M NaCl, 10 mg/ml lysozyme and protease inhibitor cocktail). The cells were disrupted by sonication on an ultrasound disintegrator. The pellet was removed by centrifugation (20,000xg, 30 min). The recombinant NS2B-NS3 construct, C-terminally tagged with a hexahistidine tag, was purified from the soluble fraction by affinity chromatography on a Co M NaCl -1 mM phenylmethylsulfonyl fluoride, the bound proteins were eluted with 60 ml of a 10-500 mM imidazole gradient. Fractions (1.5 ml) were collected and analyzed by SDS-PAGE.
The NS2B-NS3-contaning fractions were pooled and dialyzed against 10 mM Tris-HCl buffer, pH 8.0, containing 0.005% Brij 35. The dialyzed material was then incubated for 16 h at 24 o C to allow the autolytic conversion of the NS2B-NS3 construct into the individual NS3 enzyme. The resulting NS3 samples were re-checked by SDS-PAGE to confirm that autolytic conversion had been completed.
The synthesis of peptide inhibitors
The D-arginine peptide inhibitors (hexa-, hepta-, octa-, nona-, deca-, undeca-and dodeca-D-Argamides) were synthesized by solid-phase peptide synthesis. All peptides were carboxyl-terminal amidated, with free amino termini. The actual molar concentration of the peptides was lower because of the presence of water and trifluoroacetate salt in the samples. Based on kinetics and active site titration studies, we estimate that the samples contained approximately 25-35% of actual peptide. The concentrations reported in the Results section were calculated using these corrections.
Protease assays with fluorogenic peptides
The assay for NS3 protease activity was performed in 10 mM Tris-HCl buffer, pH 8.0, containing 20% glycerol and 0.005% Brij 35. The substrates and enzyme concentrations, unless indicated otherwise, were 24 µM and 10 nM, respectively. The total assay volume was 0.1 ml.
Initial reaction velocities were monitored continuously at λ ex 360 nm and λ em 465 nm on a 
Cell-based inhibitor assays and neuronal cultures
Primary sympathetic neuronal cultures were generated from superior cervical ganglia ( 
RESULTS
Purification and autolytic conversion of NS2B-NS3 into NS3
Previous studies showed that the presence of either the full-length NS2B sequence or the 40 residue central NS2B domain linked to the N-terminus of NS3 significantly enhanced the accumulation of the soluble recombinant NS3 in E.coli [18, 22] . We used a similar approach to express the WNV NS3. The 40 residue central portion of NS2B (short NS2B) was linked with NS3 via a GGGGSGGGG linker. To facilitate its isolation, the NS2B-NS3 construct was Cterminally tagged with a (His)x6 tag. To characterize the catalytic activity NS3, we expressed the short NS2B-NS3 construct in E.coli. After induction with isopropyl-β-D-thiogalactoside, large amounts of NS2B-linker-NS3 were produced as a soluble protein. The soluble fraction was loaded onto a pre-equilibrated Co
2+
-agarose affinity column. The NS2B-NS3 protein was then eluted with a 10-500 mM gradient of imidazole concentrations (Fig. 1) . The pooled, partially Under these experimental conditions, complete conversion was accomplished yielding NS3 (Fig.   1 ). The resulting NS3 samples retained the C-terminal His tag as the NS3 moiety was readily recognized by a His-tag antibody (Fig. 1) . We determined that in the course of an autolytic conversion NS3 cleaved the EYKK 15 ↓G 16 DT sequence (numbering starts from the N-terminus of NS3) that generated the individual NS3 proteinase commencing from the N-terminal G 16 ( Fig.   1 ). The catalytically inert NS2B-NS3 mutant with the H51A mutation of the active site His 51 had approximately 0.1-1% of enzymatic activity when compared to that of the autolytically activated NS2B-NS3 construct and, accordingly, this mutant was not autolytically cleaved into NS3 (data not shown). Inhibitors of NS3 completely inhibited autolysis of the NS2B-NS3 construct and its conversion into NS3 (Fig. 1) . The catalytically inert NS2B-NS3 mutant has already been crystallized and the crystallographic analysis is currently in progress (Aleshin, Shiryaev, Liddington, Strongin, in preparation). According to the results of size-exclusion chromatography (not shown), the NS2b remains non-covalently bound with the NS3 moiety after the autocatalytic cleavage of the NS2b-NS3 construct.
NS3 cleaves furin-like motifs in protein substrates
In the viral polyprotein precursor, NS3 predominantly cleaves the sequence regions with positively charged amino acid residues both at the P1 and P2 positions [12] . This cleavage preference resembles that of cathepsin B and furin [5, 27] . In our cleavage tests, WNV NS3 efficiently cleaved the furin fluorescent substrates Boc-RVRR-AMC and Pyr-RTKR-AMC, while the cleavage of the cathepsin B substrate Z-RR-AMC was significantly less efficient ( 
Potential host cell proteins with NS3 cleavage sites
After the maturation of the viral proteins and the formation of the virion, the NS3 proteinase is released from the infected, dead host cells [30] . After its release, the catalytically active NS3 can engage host cell targets and contribute independently to WNV pathogenesis. To identify the proteins which may be useful as the substrates of NS3 for the subsequent in vitro studies as well as to narrow the number of the putative cleavage targets, we used the known cleavage preference of NS3 to construct a probabilistic cleavage profile of the NS3 protease. For these purposes, we used PoPS, a system for the Prediction of Protease Specificity (http://pops.csse.monash.edu.au).
Recently, a PoPS analysis of the human proteome was successfully used in our laboratory for an in silico prediction of the potential cleavage targets of membrane type-1 matrix
To perform PoPS searches, the protein sequences, known to be susceptible to NS3 proteolysis, were used to generate a position-specific scoring matrix (on a scale of -5.0 to +5.0)
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for the P4-P4' cleavage positions of the known NS3 protein and peptide substrates. This software uses the scoring matrix rather than the sequence motif in searching for cleavage targets [32] .
PoPS was then used to search for the presence of the NS3 cleavage profile in the human proteome (28,796 proteins). Because in our search motif the amino acid residues other than positively charged Arg and Lys occupied the P4 position, the substrates of furin (which require the presence of positively charged residues at the P4) would not be identified in our searches. To filter these predictions further, the programs PSIPRED and NCOILS (integrated in the PoPS system) were used to predict the secondary structure of the potential protein targets and to search for cleavage sites that are located in unstructured regions.
This analysis returned a score for each identified site, based on the weighted matrix. The analysis revealed 28 top scoring hits with the score=46-48 in the human proteome, as shown in Table 2 . The identified hits were predominantly represented by the hypothetical and predicted proteins and by the proteins without any obvious physiological relevance to the NS3 function.
The analysis also identified two brain proteins, which may be relevant to the biology of WNV:
myelin basic protein (MBP) and myelin protein zero (PoPS score of both = 46). These proteins are required for the normal functioning of neurons and, their absence or mutation is associated with neuron degeneration and neurological pathologies [33] [34] [35] [36] .
To confirm the validity of PoPS prediction, we evaluated the ability of NS3 to cleave MBP in vitro. As predicted, MBP was highly sensitive to specific cleavage by WNV NS3 (Fig.   4 ).
D-Arg-based peptides and serpins are the NS3 inhibitors
D-Arg-based peptides and serine protease inhibitors (serpins) are potent inhibitors of furin [23, 37] . Based on our data that show that NS3 has furin-like activity, we tested whether similar peptide and protein inhibitors would inhibit WNV NS3. The sixmer-twelvemer D-Arg peptides were effective at a nanomolar range against the WNV NS3 proteinase in vitro (Table 3) .
Consistent with these findings, NS3 was also sensitive to a well-known inhibitor of furin, α1-anti-trypsin variant Portland [38] . Among the protein inhibitors examined, aprotinin was most (Fig. 4) . Table 3 shows that the K i of the D-Arg peptide for furin increased from 36 nM to 100 nm as the chain length decreased from 9 to 6 residues. In contrast, the Ki of hexa-DArg-NH 2 for NS3 was 80-100-fold higher when compared to that of nona-D-Arg-NH 2 peptide.
These findings suggest that there is a significant difference in the binding mode of the positively charged inhibitors with furin and with NS3. To identify this difference, we built a spatial model of WNV using a known structure of Dengue virus NS3 as a template [19, 39] .
Modeling of the spatial structure of NS3
Because the level of homology between the West Nile and Dengue NS3 is high (above 50%), we could produce the model of WNV NS3 (the RMSD=0.21 Å) (Fig. 5) . This model was be used to guide our studies until the actual crystallographic structure of NS3 becomes available. The in silico model of the NS3 proteinase shows a low density of negatively charged residues in the proximity of the catalytic triad and this structural relationship emphasizes the importance of the two Asp residues (Asp-75 and Asp-129) (Fig. 5) . According to this model, there are no negatively charged residues, except Asp-75 and Asp-129, in the active site groove of WNV NS3.
We suspect that these two residues of NS3 interact with the positively charged Arg-based antagonists. In contrast, the number of negatively charged residues is high in furin's catalytic site region [27, 40] .
Cell-based assays confirm the inhibitory effect of D-Arg-based peptides
Although our in vitro data suggested that D-Arg based peptides had the capacity to inhibit NS3 proteinase activity, it was important to confirm the relevance of this finding. To assess this, we treated primary neurons with increasing concentrations of nona-D-Arg-NH 2 and then infected them with the pathogenic New York strain of WNV. At a 10-50 µM range of peptide, a several log reduction of virus production was observed (Fig. 6 ). There was no significant non-specific 
DISCUSSION
In this study, we purified and partially characterized the NS3 processing proteinase from West Nile flavivirus. Our purified NS3 samples were homogeneous as shown by SDS-PAGE and demonstrated a high proteolytic activity against model peptide substrates of furin. In contrast to an opposing theory that the resulting NS3 is inactive if the activator NS2B sequence is absent [18, 21, 22] , our studies suggest that the NS2B sequence represents a prodomain, rather than a cofactor or activator of the 30 kDa NS3 proteinase. It appears that the NS2B sequence functions as an autolytically-cleaved prodomain, which is essential for the proper folding and, consequently, the activity of the NS3 proteinase. As with bacterial proteinases (subtilisin and thermolysin) and mammalian furin [27, [41] [42] [43] [44] , the viral NS2B, most probably stabilizes the folding intermediates [45] [46] [47] [48] on the path to the fully folded/active catalytic domain of NS3.
Because the individual NS3 was catalytically active in the peptide and protein cleavage assays, we believe that the presence of the covalently bound NS2B sequence is not required for the enzymatic activity of NS3.
Our studies determined that NS3 exhibited furin-like, albeit less restricted, cleavage preferences. These distant relationships between furin and NS3 led us to hypothesize that there are common inhibitors of these proteinases. This hypothesis facilitated the identification of the inhibitors of NS3. Thus, the D-Arg-based peptides are nanomolar range inhibitors of NS3 in vitro.
Based on the modeling of the three-dimensional structure of WNV NS3, we suggest that recombinant NS3 proteases from all four serotypes of dengue virus using tetra-and octa- Table 3 ).
The data show that NS3 (2 µM) is fully inhibited by 12(D-Arg)-amide at a 2-200 µM range. The data also show that NS3 (2 µM) is fully inhibited by aprotinin at a 20-120 µM range and is partially inhibited at a 1-5 µM range. 
